The latest notice of a funding opportunity for the Cancer Center Support Grants released by NCI no longer requires submission of a Plan to Enhance Diversity.
A federal judge ruled that the FDA lacks the statutory authority to regulate laboratory developed tests, finding squarely in favor of plaintiffs in the consolidated lawsuits brought by American Clinical Laboratories Association, Association for Molecular Pathology, and others. ASCP submitted an amicus brief supporting the plaintiffs.
